Joint Formulary & PAD

Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Search

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Chronic Kidney Disease (Sucroferric oxyhydroxide - Hyperphosphataemia)

Records returned : 4 (on 26 Jan 2026 at 09:24:38). Return to search results for ' Chronic Kidney Disease '.

Show Icon and Status Keys

Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Red
Restrictions / Comments:

Important

Hyperphosphataemia in patients with chronic kidney disease

Not on Surrey Heartlands Trust formularies. Trusts with renal centres (locally this is Epsom, Frimley & Brighton) will retain prescribing responsibility’.

 
Links :
R
SPC
Indication :
Status :
Red
Formulations :
  • Tablets
Restrictions / Comments:

Important

To be used for hyperphosphataemia associated with pemigatinib used in accordance with the SACT protocol

 
Links :
SPC
Indication :
Status :
Red
Restrictions / Comments:

Important

Hyperphosphataemia in patients with chronic kidney disease

Not on Surrey Heartlands Trust formularies. Trusts with renal centres (locally this is Epsom, Frimley & Brighton) will retain prescribing responsibility’.

 
Links :
Off Label
R
SPC
Indication :
Status :
Red
Formulations :
  • Oral suspension
  • Tablets
Restrictions / Comments:

Important

Symptomatic anaemia associated with chronic kidney disease

Not on Surrey Heartlands Trust formularies. Trusts with renal centres (locally this is Epsom, Frimley & Brighton) will retain prescribing responsibility’.

 
Links :
Off Label
R